Skip to main content
IDEX Biometrics ASA logo

IDEX Biometrics ASA — Investor Relations & Filings

Ticker · IDEX ISIN · NO0013107490 LEI · 5967007LIEEXZXHECW11 OL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 1,330 across all filing types
Latest filing 2020-11-24 AGM Information
Country NO Norway
Listing OL IDEX

About IDEX Biometrics ASA

https://www.idexbiometrics.com/

IDEX Biometrics ASA is a technology company specializing in fingerprint identification and biometric authentication solutions. The company designs, develops, and commercializes proprietary fingerprint sensors and software for integration into smart cards. Its core products are biometric payment cards and access cards, which provide enhanced security for financial transactions and identity verification. The technology stores and matches the user's fingerprint data directly on the card, ensuring that sensitive biometric information is never stored in the cloud. This on-card approach enables secure and convenient authentication with a simple touch, replacing traditional PINs and passwords. The solutions are certified by major payment networks like Visa and Mastercard and are compliant with FIDO standards for strong online authentication, offering protection against phishing and other cyber threats for both payment and access control systems.

Recent filings

Filing Released Lang Actions
IDEX Biometrics - Notice of Extraordinary General Meeting on 15 December 2020
AGM Information Classification · 98% confidence The document is explicitly titled "NOTICE OF EXTRAORDINARY GENERAL MEETING IN IDEX BIOMETRICS ASA" and details the date, time, and agenda items for this meeting (e.g., Election of the Board of Directors, Approval of Indemnification Agreements, Subscription Rights Incentive Plan, Authorizations to the Board to issue new shares). This content is characteristic of materials prepared for a shareholder meeting, specifically soliciting votes or providing necessary information for that meeting. While it relates to corporate governance and capital structure, the primary function is to convene and inform shareholders about the meeting agenda. This aligns best with the definition of materials related to a General Meeting, which often overlaps with Proxy Solicitation (PSI) or AGM-R. Since it is an *Extraordinary* General Meeting (EGM) notice detailing proposals requiring shareholder approval, it strongly suggests Proxy Solicitation/Information Statement (PSI) or, given the context of a formal notice for a meeting, AGM-R (which covers AGM materials, and EGMs often use similar documentation structures). Given the focus on the 'Notice' and the agenda items requiring shareholder resolution, AGM-R is the most appropriate fit for a formal meeting notice, although PSI is also highly relevant. I will select AGM-R as it directly names the meeting type contextually, even if it's an EGM rather than an AGM.
2020-11-24 English
IDEX Biometrics - Notice of Extraordinary General Meeting on 15 December 2020
AGM Information Classification · 98% confidence The document is explicitly titled "IDEX Biometrics - Notice of Extraordinary General Meeting on 15 December 2020". This document serves as the official notification to shareholders regarding an upcoming general meeting (EGM), detailing the date, time, location (online), and key agenda items, such as the election of the Board and authorization requests. This directly corresponds to the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting, and by extension, Extraordinary General Meetings (EGM) notices.
2020-11-24 English
IDEX Biometrics - Private placement successfully completed, raising NOK 70 million
Capital/Financing Update Classification · 98% confidence The document explicitly announces the successful completion of a 'Private placement successfully completed, raising NOK 70 million'. It details the number of new shares issued, the price, the use of proceeds (funding growth, general corporate purposes), and includes disclosures regarding insider subscriptions (Director's Dealing). This content directly relates to fundraising and capital structure changes, fitting the definition of 'Capital/Financing Update'. It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), but a specific announcement about capital raising.
2020-11-10 English
IDEX Biometrics to Participate at the ROTH Technology Virtual Event
Report Publication Announcement Classification · 99% confidence The document is a short announcement stating that IDEX Biometrics ASA will be participating in the 'ROTH Technology Virtual Event Conference 2020' on specific dates. It mentions that supporting presentation materials will be available on the company website on the date of the event. This structure—announcing participation in an external investor event and noting that presentation materials will follow—is characteristic of an announcement about future investor engagement, rather than a formal regulatory filing like a 10-K, ER, or IR. Since it is an announcement related to investor relations activities (conference participation), it fits best under the general 'Regulatory Filings' (RNS) category as a miscellaneous corporate announcement, or potentially an Investor Presentation (IP) if the materials were attached, but since it only announces participation and future material availability, RNS is the most appropriate general classification for this type of corporate update that doesn't fit a more specific category like DIV or DIRS. Given the options, RNS serves as the best fit for a general corporate/investor event participation notice.
2020-11-06 English
IDEX Biometrics - Interim Report for the First Nine Months of 2020
Investor Presentation Classification · 99% confidence The document is explicitly titled "Q3 2020 - Presentation" and contains extensive slides detailing recent highlights, investment highlights (market size, certification, sales momentum), consumer benefits, market activation milestones, technology comparison, financial model structure, and a 'Financial Summary' reporting Q3 2020 revenue and margin figures compared to Q3 2019. This structure—a presentation format summarizing quarterly performance, strategy, and outlook—is characteristic of an Investor Presentation (IP), often used in conjunction with or immediately following an Earnings Release (ER). Since it is a detailed presentation deck rather than a brief press release (ER) or a comprehensive regulatory filing (IR/10-K), Investor Presentation (IP) is the most appropriate classification.
2020-11-05 English
IDEX Biometrics - Interim Report for the First Nine Months of 2020
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT THIRD QUARTER 2020' and contains detailed financial statements, including statements of profit and loss, revenue analysis, operating expenses, and management commentary on business performance for the specified period. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. Q3 2020
2020-11-05 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.